发明名称 FILAGGRIN PRODUCTION PROMOTER, THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH REDUCTION IN PRODUCTION OF FILAGGRIN, AND METHOD FOR SCREENING FOR SAID THERAPEUTIC AGENT
摘要 The present invention provides a highly effective substance having a filaggrin production-promoting action. The present invention also provides a therapeutic agent useful for treating a skin disease, in particular, atopic dermatitis associated with reduced filaggrin production. As a result of intensive studies on a filaggrin production promoter, it has been found that A) an N-quinolylbenzamide derivative (Compound 1), B) ivermectin (Compound 2), or C) a phenylalaninamide derivative (Compound 3) promotes production of filaggrin in skin and satisfactorily improves a water retention ability and barrier function of the stratum corneum. The present invention relates to a filaggrin production promoter containing a certain N-quinolylbenzamide derivative or a pharmaceutically acceptable salt thereof as an active ingredient.
申请公布号 US2015190416(A1) 申请公布日期 2015.07.09
申请号 US201314414940 申请日期 2013.07.12
申请人 KYOTO UNIVERSITY ;ASTELLAS PHARMA INC. 发明人 Kabashima Kenji;Otsuka Atsushi;Egawa Gyohei;Doi Hiromi;Maekawa Akiko;Narumiya Shuh
分类号 A61K31/7048;A61K31/4439;C12Q1/68;A61K31/47 主分类号 A61K31/7048
代理机构 代理人
主权项 1. A therapeutic agent for a disease associated with reduced filaggrin (FLG) production, comprising a GPR142 agonist as an active ingredient.
地址 Kyoto JP